Silicon Valley Cash Is Still Chasing Blood Despite Theranos Bust
Bloomberg- January 6, 2017
Blood is still pumping in Silicon Valley
Blood tests: Genalyte continues its march forward despite the scandal Theranos
LesEchos- January 3, 2017
10 Tech Advances That Can Change Medicine
MedScape- December 16, 2016
Microfluidic Chips for Labs via a Droplet of Blood
Sticking Points
ACS Central Science- December 16, 2016
Raising the quality of fingerprick blood testing will require innovation at every stage of the process.
Genalytea s Diagnostic Tool Shows Potential to Improve Turnaround Time in RA, Other Conditions
Rheumatoid Arthritis News- November 29, 2016
Genalyte recently presented promising data on its new Maverick Detection System, demonstrating its potential to be used in a near patient setting to improve turnaround time for test results and diagnosis for several conditions, including rheumatoid arthritis (RA).
Genalyte Inc. Receives $36 Million in Latest Funding Round
San Diego Business Journal- November 23, 2016
Genalyte Inc. has landed $36 million in funding to accelerate the development of its blood-testing technology.
Genalyte Raises $36M in Funding
GenomeWeb- November 21, 2016
San Diego-based Genalyte will use the funds to further refine its Maverick Detection System, a photonic microring sensor-based platform that the company is developing for rapid blood testing in outpatient settings like doctors’ offices.
Genalyte raises $36 million from Khosla for its one-drop blood test
TechCrunch- November 21, 2016
Genalyte just announced it has raised an equity round of $36 million in funding led by Khosla Ventures and Redmile Group.
A startup that’s developing tests that run on a drop of blood just raised $36 million
Business Insider- November 20, 2016
On Sunday, Genalyte, a company that’s developing tests that run on a drop of blood, raised a $36 million round of funding from Khosla Ventures and Redmile Group.
The Bloomberg Advantage: Genalytea s Rapid Diagnostic Testing
BloombergA – March 7,A 2016
Cary Gunn CEO/Founder Genalyte Inc Discussing providing rapid diagnostic testing right in the doctora s office from a single drop of blood.
The technology behind Theranos could still disrupt the entire lab business
Tech InsiderA -A FebruaryA 10,A 2016
Theranos is under a lot of heat these days. But even if the controversial biotech startupA fails, it was right about one major thing: the blood testing experience is ripe for disruption.
Genalyte is taking the single fingertip blood test to the next level (yet another Theranos competitor)
Medcity NewsA – January 8,A 2016
The hype about a single fingertip-prick blood test has clearly become mainstream at this point, especially considering Theranosa somewhat unfortunate publicity. But some companies, Genalyte for example, are taking a similar approach a more closely in comparison than some others.
Redefining diagnostics: An industry view
The HillA -A November 10,A 2015
As the CEO of an emerging diagnostics company, I speak with patients and doctors on a regular basis, and am struck by how poorly the industry is serving their needs. The current patient experience is miserable.
Genalyte to Use $44M Funding Round to Pursue FDA Clearance for Multiplexed Immunoassay Device
Genome WebA – August 21,A 2015
Having recently closed a $44 million Series C financing round, biotech firm Genalyte aims to use the funds to develop its Maverick biosensor system for rapid, routine testing in doctors’ office.
Genalyte raises $44 million
The San Diego Union-TribuneA – August 18,A 2015
Genalyte, a San Diego biomedical company, said Tuesday it has raised $44 million from venture capital firms. The money will help Genalyte commercialize its diagnostics system, which produces test results in minutes from one drop of blood…
Genalyte Raises $44M in Series C Financing
Genome WebA – August 18,A 2015
San Diego-based diagnostics firm Genalyte today announced it has completed a $44M Series C financing round.A Khosla Ventures joined previous investors Redmile Group, Claremont Creek Ventures, and BioMed Ventures in the round…
Khosla backs Genalyte in $44M round to move blood-based diagnostics into the doctor’s office
Fierce Medical Devices – August 18,A 2015
Move over Theranos, here comes Genalyte. The former has made a big splash in the last year as it works to make diagnostics that are cheaper, require only a drop of blood and directly available to consumers…
Genalyte, Collaborators Gear Up for Phase Two of Tumor-associated Antigen Panel Development
Genome Web – February 3,A 2015
Since the grant was awarded and the project began in fall of 2013,A GenalyteA has developed an initial panel of 39 of the most promising TAAsA …
Genalyte Developing Differential Ebola Test for Maverick Chip-based System
Genome Web – January 20,A 2015
Now, though,A GenalyteA has developed a test that it says can tell whether a patient has Ebola or one of a number of other similar diseases…
Company unveils 10-minute Ebola test
CNNA – December 2,A 2014
Genalyte has developed a rapid response blood test which can detect the deadly virus in 10 minutes…
US firm working on a 20-minute Ebola test
BBC World Services – November 7, 2014
Time is of the essence when it comes to fighting the Ebola virus…
Load More
Race Is On to Detect Ebola More Quickly
The Wall Street Journal – November 5, 2014
Researchers Seek Crucial Tool: A Fast, Finger-Prick Ebola Test
The New York Times – November 5, 2015
Local Company Develops New 10 Minute Diagnostic Ebola Test
San Diego 6 – October 29, 2014
Pine Belt Native Revolutionizing Ebola Testing
WHLT – October 28, 2014
San Diego company develops 10-minute EbolaA test
Fox 5 San Diego – October 27, 2014
New Ebola test could make diagnosing disease easier
Yahoo Finance – October 27, 2014
10-minute Ebola diagnostic test announced by startup company
Fox News – October 27, 2014
Local research: Ebola test results in 10 minutes
CBS 8 – October 24, 2014
10-minute Ebola test announced
UT San Diego – October 22, 2014
Company touts 10-minute Ebola test
The Hill – October 21, 2014
Tests for Ebola Hampered by Lukewarm Funding, Scientists Say
CQ Healthbeat News – October 21, 2014
Genalyte Expands Into Cancer Profiling With $1 Million NCI
PR News Wire – October 18, 2013
Genalyte Launches Type 1 Diabetes Antigen Panel, BDC
Genetic Engineering and Biotech News – August 15, 2013
Biomarker panel is companya s first step toward a tool for early detection of type 1 diabetes
MedCity News – August 15, 2013
Genalyte, Inc. Completes $12 Million Series B Financing to Commercialize Its Maverickac Next-Generation Multiplexing Platform
PR News Wire – March 30, 2102
Genalyte Inc. raises $12 million in second venture round
Biz Journal – March 30, 2012
Imec reveals chip-based hyperspectral imager, biosensor partnership, and spinoff funding
Laser Focus World – January 31, 2012
Imec, Genalyte report disposable silicon photonics biosensor chips
Phys – January 25, 2012